Aktieanalys

BioInvent: New Clinical Trial Collaboration and Supply Agreement with MSD - Redeye

{newsItem.title}

Redeye Publicerad: 03 Apr 10:45

Redeye is optimistic about the new agreement with MSD/Merck to provide Keytruda for the combination part of the phase I/IIa study of BI-1910.

Länk till analysen i sin helhet: https://www.redeye.se/research/993654/bioinvent-new-clinical-trial-collaboration-and-supply-agreement-with-msd?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt